A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia

Publication | Closed Access

DOI

176

Citations

References

2004

Year

Harold Bays, Leiv Ose, Neil J. Fraser, Diane L. Tribble, Katherine Quinto, Robert Reyes, Amy O. Johnson‐Levonas, Aditi Sapre, Steven Donahue

Clinical Therapeutics

Metabolic SyndromeThrombosisPrimary HypercholesterolemiaNon-pharmacological InterventionLipid DisorderHealth PolicyCardiovascular DiseaseEzetimibe/simvastatin TabletSimvastatin MonotherapyHyperlipidemiaPharmacotherapyPublic HealthMedicineAtherosclerosisDyslipidemia